Trial intelligence / Profile preview

TDF+3TC+EFV Regimen in ART-naive Chinese HIV-1 Patients

NCT01844297Phase 4Unknown

Sponsor
Peking Union Medical College
Start
May 2013
Primary completion
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tenofovir disoproxil fumarate, lamivudine, efavirenz in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Peking Union Medical College. Status: unknown.

02

Drugs

tenofovir disoproxil fumaratelamivudineefavirenz
03

Conditions

human immunodeficiency virus type 1 infection (HIV-1)

Beyond the preview

Go deeper on NCT01844297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01844297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call